ZA953206B - High solubility multicomponent inclusion complexes consisting of an acidic drug a cyclodextrin and a base - Google Patents

High solubility multicomponent inclusion complexes consisting of an acidic drug a cyclodextrin and a base

Info

Publication number
ZA953206B
ZA953206B ZA953206A ZA953206A ZA953206B ZA 953206 B ZA953206 B ZA 953206B ZA 953206 A ZA953206 A ZA 953206A ZA 953206 A ZA953206 A ZA 953206A ZA 953206 B ZA953206 B ZA 953206B
Authority
ZA
South Africa
Prior art keywords
cyclodextrin
base
inclusion complexes
high solubility
acidic drug
Prior art date
Application number
ZA953206A
Other languages
English (en)
Inventor
Paolo Chiesi
Paolo Ventura
Maurizio Del Canale
Maurizio Redenti
Daniela Acerbi
Massimo Pasini
Josef Szettli
Maria Vikmon
Eva Fenyvesi
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of ZA953206B publication Critical patent/ZA953206B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nanotechnology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Public Health (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
ZA953206A 1994-04-22 1995-04-20 High solubility multicomponent inclusion complexes consisting of an acidic drug a cyclodextrin and a base ZA953206B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI940790A IT1269578B (it) 1994-04-22 1994-04-22 Complessi di inclusione multicomponente ad elevata solubilita' costituiti da un farmaco di tipo acido, una ciclodestrina e una base.

Publications (1)

Publication Number Publication Date
ZA953206B true ZA953206B (en) 1996-01-03

Family

ID=11368715

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA953206A ZA953206B (en) 1994-04-22 1995-04-20 High solubility multicomponent inclusion complexes consisting of an acidic drug a cyclodextrin and a base

Country Status (12)

Country Link
US (1) US5773029A (de)
EP (1) EP0756493B1 (de)
AT (1) ATE194777T1 (de)
AU (1) AU2307695A (de)
CA (1) CA2188388A1 (de)
DE (1) DE69518070T2 (de)
ES (1) ES2148512T3 (de)
IL (1) IL113450A (de)
IT (1) IT1269578B (de)
PT (1) PT756493E (de)
WO (1) WO1995028965A1 (de)
ZA (1) ZA953206B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7637296A (en) * 1995-11-14 1997-06-05 Farmarc Nederland Bv Complex of naproxen and beta-cyclodextrin
ES2224205T3 (es) * 1996-05-07 2005-03-01 Pfizer Inc. Metodo de seleccionar una sal para la fabricacion de un complejo de ionclusion.
UA57734C2 (uk) 1996-05-07 2003-07-15 Пфайзер Інк. Комплекси включення арилгетероциклічних солей
US6383471B1 (en) 1999-04-06 2002-05-07 Lipocine, Inc. Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
US6939863B2 (en) 2002-01-04 2005-09-06 Wei-Jan Chen Prevention of atherosclerosis and restenosis
JP4732696B2 (ja) * 2002-04-09 2011-07-27 フラメル・テクノロジー 活性成分の改変された放出のための、マイクロカプセルの水性懸濁液形態での経口医薬品製剤
ATE359827T1 (de) * 2002-06-17 2007-05-15 Chiesi Farma Spa Prozess für die vorbereitung von piroxicam: beta- cyclodextrin einschlusskomplexe
NZ537995A (en) * 2002-08-20 2007-11-30 Bristol Myers Squibb Co Inclusion complex of aripiprazole in a substituted b-cyclodextrin
DE10260872B4 (de) * 2002-12-23 2013-09-26 Beiersdorf Ag Verwendung von gelbildendem Polymer, Wasser, Alkohol und Meeresalgenextrakt zur Einstellung von Elastizität und Haftvermögen selbstklebender kosmetischer Polymermatrices
US7993654B2 (en) * 2002-12-23 2011-08-09 Beiersdorf Ag Self-adhesive polymer matrix containing sea algae extract
DE10260873A1 (de) 2002-12-23 2004-07-15 Beiersdorf Ag Selbstklebende Polymermatrix mit einem Gehalt an Meeresalgenextrakt und Glycerin
US20070020578A1 (en) * 2005-07-19 2007-01-25 Scott Robert R Dental curing light having a short wavelength LED and a fluorescing lens for converting wavelength light to curing wavelengths and related method
WO2006034147A2 (en) * 2004-09-16 2006-03-30 Abraxis Bioscience, Inc. Compositions and methods for the preparation and administration of poorly water soluble drugs
US8772346B2 (en) * 2005-11-09 2014-07-08 Torrent Pharmaceuticals Limited Pharmaceutical composition
FR2914187B1 (fr) * 2007-03-28 2011-01-21 Pf Medicament Complexes d'ibuprofene, de cyclodextrines et d'agents ternaires, et leurs utilisations en pharmaceutique.
KR101522918B1 (ko) 2009-05-29 2015-05-27 사이덱스 파마슈티칼스, 인크. 사이클로덱스트린 유도체를 포함하는 주사용 멜팔란 조성물 및 이의 제조 및 사용 방법
US11020363B2 (en) 2009-05-29 2021-06-01 Cydex Pharmaceuticals, Inc. Injectable nitrogen mustard compositions comprising a cyclodextrin derivative and methods of making and using the same
CN108210501B (zh) * 2016-12-14 2019-03-08 中国人民解放军军事医学科学院毒物药物研究所 一种磺酰脲类药物的注射用药物组合物及其制备方法
WO2022187567A2 (en) 2021-03-04 2022-09-09 Biogen Chesapeake Llc Low-sorbing glyburide formulation and methods

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1196033B (it) * 1984-02-22 1988-11-10 Chiesi Farma Spa Composto ad attivita' antiinfiammatoria ottenuto per complessazione con beta-ciclodestrina e relative formulazioni farmaceutiche
ZW18088A1 (en) * 1987-12-22 1989-07-26 Glaxo Group Ltd Aqueous formulations containing a piperidinylcyclopentylheptenoic acid derivative
IT1263831B (it) * 1993-01-29 1996-09-04 Paolo Chiesi Complessi di inclusione multicomponente ad elevata solubilita' costituiti da un farmaco di tipo basico, un acido ed una ciclodestrina

Also Published As

Publication number Publication date
IL113450A0 (en) 1995-07-31
DE69518070T2 (de) 2001-01-11
EP0756493A1 (de) 1997-02-05
WO1995028965A1 (en) 1995-11-02
PT756493E (pt) 2000-10-31
IL113450A (en) 1999-05-09
DE69518070D1 (de) 2000-08-24
IT1269578B (it) 1997-04-08
US5773029A (en) 1998-06-30
ES2148512T3 (es) 2000-10-16
CA2188388A1 (en) 1995-11-02
ATE194777T1 (de) 2000-08-15
AU2307695A (en) 1995-11-16
ITMI940790A1 (it) 1995-10-22
EP0756493B1 (de) 2000-07-19
HK1013627A1 (en) 1999-09-03
ITMI940790A0 (it) 1994-04-22

Similar Documents

Publication Publication Date Title
IL113450A0 (en) High solibility multicomponent inclusion complexes consisting of an acidic drug, a cyclodextrin and a base
DK1036058T3 (da) Adamantanderivater
DE69808130D1 (de) Adamantan-derivate
BG101139A (en) Heteroatoms-containing cyclopentanopyridyloxazolidinons
BG104056A (en) Triazole compounds and their use as dopamine-d3-ligands
HU9503605D0 (en) Use of nona- and decapeptides in the preparation of a drug for the treatment of aids
SE9704546D0 (sv) Novel compounds
HU9502251D0 (en) Highly soluble multicomponent inclusion complexes containing a base type drug, an acid and a cyclodextrin
DE69106714D1 (en) Hypoglykämische hydroxyharnstoffderivate.
MY125978A (en) Admantane derivatives
IT1243193B (it) Composizioni farmaceutiche orali a base di melatonina
TR200001102T2 (tr) İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları.
AU6814701A (en) Methods and compositions for producing a neurosalutary effect in a subject
MX9804068A (es) Nuevos derivados de quinoxalindiona, su preparacion y empleo en medicamentos.
AU5269696A (en) Anellated beta-carbolines
HRPK921028B1 (en) Binder for heat-set colours
ES1031984U (es) Expositor perfeccionado.
NZ517348A (en) Use of a mycobacterial extract in the treatment of inflammatory bowel disease
ZA942972B (en) New quinoxalinedione derivatives, their production and use in pharmaceutical agents.
IT8920729V0 (it) Dispositivo gemello per l'azionamento di tappi di servizi igienici, in particolare di lavelli da cucina.